These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23302346)

  • 1. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 4. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
    Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
    Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
    Yasuda M
    J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammaglobin expression in gynecologic adenocarcinomas.
    Hagemann IS; Pfeifer JD; Cao D
    Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoexpression and clinical significance of the PTEN and MLH1 proteins in endometrial carcinomas.
    Bąkiewicz A; Michalak J; Sporny S
    Pol J Pathol; 2010; 61(4):185-91. PubMed ID: 21290340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
    Abu Backer FM; Mustapha NR; Othman NH
    Anal Quant Cytol Histol; 2011 Oct; 33(5):283-8. PubMed ID: 22611756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Huang W; Cheng X; Ji J; Zhang J; Li Q
    Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathology of ovarian lesions: the intraoperative approach.
    Jiménez-Ayala M; Jiménez-Ayala Portillo B
    Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
    Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
    Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
    Ramalingam P; Masand RP; Euscher ED; Malpica A
    Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
    Guo DH; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
    [No Abstract]   [Full Text] [Related]  

  • 16. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma.
    Missaoui N; Salhi S; Bdioui A; Mestiri S; Abdessayed N; Mokni M; Yacoubi MT
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2545-2551. PubMed ID: 30256049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
    Miller EM; Tymon-Rosario J; Sunkara J; Harmon BE; Karabakhtsian RG; Novetsky AP
    Int J Gynecol Cancer; 2018 Sep; 28(7):1318-1324. PubMed ID: 30036224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases.
    Wei JJ; Paintal A; Keh P
    Arch Pathol Lab Med; 2013 Nov; 137(11):1574-83. PubMed ID: 24168495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.